Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

FDA Public Workshop on Developing Animal Models of Pregnancy to Address Medical Countermeasures for Influenza

 

The Food and Drug Administration (FDA) is announcing a public workshop to provide a forum to carefully consider scientific issues related to selecting animal models for use in evaluating medical influenza countermeasures (anti-influenza drugs) that may be given during pregnancy. Specifically, this workshop will address experimental design issues in selecting the most appropriate animal model that mimics human pregnancy. The goal is to use this model to evaluate how pregnancy changes the pharmacokinetics of anti-influenza drugs in animals and compare those changes to the changes that are known to occur in human pregnancy. The data obtained from using this model may enhance the knowledge base needed to extrapolate the effects of pregnancy on other medical countermeasures.

Date: April 30 - May 1, 2012

Time: 8:30 am to 5:00pm (both days)

Location:  FDA White Oak Campus
                   10903 New Hampshire Avenue
                   Bldg 2, Room 2047
                   Silver Spring, Maryland 20993

Federal Register Noticedisclaimer icon

For Further Information Contact: Cindy de Sales using the email address cindy@tepgevents.com or telephone number 240-316-3207

 

 

-
-